GLP-1 Medical Weight Loss - Semaglutide & Tirzepatide
Both LocationsGLP-1 (Glucagon-Like Peptide-1) receptor agonist medications represent the most significant advance in non-surgical weight management in decades. At Stay Ageless Clinic in Plainview, NY and Center Moriches, two GLP-1 medications are available: Semaglutide - commercially available as Ozempic (weekly injection, diabetes indication) and Wegovy (weekly injection, weight loss indication) - and Tirzepatide - commercially available as Mounjaro (dual GLP-1 and GIP agonist, diabetes indication) and Zepbound (weight loss indication).
Both work by mimicking the gut hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity - producing significant sustained weight reduction in most patients. Average weight loss is 15-20% of body weight with semaglutide and 20-22% with tirzepatide over 68-72 weeks.
At Stay Ageless Clinic, GLP-1 programs are medically supervised - Farina Sial, PA, MBA reviews medical history, contraindications, and baseline bloodwork before prescribing. Programs include quarterly monitoring bloodwork, dose titration guidance, and complementary aesthetic planning for patients experiencing facial volume loss (GLP-1 face) or skin laxity from rapid weight reduction.